The Phoenix Site is Numinus’ Third Research Facility in the US VANCOUVER, BC, Feb. 17, 2023 /PRNewswire/ – Numinus Wellness Inc. (“Numinus”) (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it has expanded its clinical research capabilities into Arizona. The site…


Previous articlePioneering Delix Therapeutics Study Published in ‘Science’ Elucidates the Mechanism of Psychedelic-Induced Neuroplasticity
Next articleBright Minds Biosciences Announces Non-Executive Director Appointment